Decreased Asthma Exacerbations and Hospitalizations in PROSPERO (Prospective Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab)

Rationale Real-world data are important to supplement clinical trial data in heterogeneous diseases like asthma.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB8-AB8
Main Authors: Chipps, Bradley W., MD, Busse, William, MD, Luskin, Allan T., MD, Zeiger, Robert S., MD, PhD, FAAAAI, Trzaskoma, Benjamin L., MS, Griffin, Noelle M., PhD, Antonova, Evgeniya, MS, PhD, Limb, Susan L., MD, Casale, Thomas B., MD, FAAAAI
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Hospitalization
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rationale Real-world data are important to supplement clinical trial data in heterogeneous diseases like asthma.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.080